Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial

Scott N Gettinger, Mary W Redman, Lyudmila Bazhenova, Fred R Hirsch, Philip C Mack, Lawrence H Schwartz, Jeffrey D Bradley, Thomas E Stinchcombe, Natasha B Leighl, Suresh S Ramalingam, Susan S Tavernier, Hui Yu, Joseph M Unger, Katherine Minichiello, Louise Highleyman, Vassiliki A Papadimitrakopoulou, Karen Kelly, David R Gandara, Roy S Herbst

JAMA Oncology, 2021 Jul 15

Abstract link